Lv4
515 积分 2020-04-19 加入
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
10天前
已完结
ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms race
1个月前
已完结
[Guidelines on tests of PIK3CA mutation in breast cancer in China (2025 version)]
5个月前
已完结
[Clinical practice guideline for molecular pathology in colorectal cancer (2025 version)]
5个月前
已完结